Adaptive Immune Response in Type 1 Diabetes

Type 1 diabetes (T1D) is primarily an autoimmune disorder characterized by the adaptive immune system's attack on insulin-producing beta cells in the pancreas. This immune response involves the activation of autoreactive T cells, which recognize beta cell antigens and lead to their destruction. Environmental triggers, such as viral infections, along with genetic predispositions, can initiate this process. Understanding the mechanisms behind this adaptive immune response is critical for developing therapies aimed at preventing or reversing T1D, including immunotherapy strategies that could potentially halt the progression of the disease and preserve residual beta cell function.